Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.
Quick Facts
What This Study Found
Serum substance P concentrations were significantly different between osteoarthritis and rheumatoid arthritis patients and positively correlated with chronic pain intensity in both groups.
Key Numbers
How They Did This
The study enrolled patients diagnosed with osteoarthritis and rheumatoid arthritis and measured their serum substance P levels. Pain intensity was assessed and correlated with substance P concentrations to evaluate their relationship.
Why This Research Matters
Understanding the link between substance P and chronic pain could help develop targeted treatments for inflammatory joint diseases, improving pain management.
What This Study Doesn't Tell Us
The study type and evidence strength were not specified, and the sample size and control details are unclear, limiting the ability to generalize findings.
Trust & Context
- Original Title:
- Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.
- Published In:
- PloS one, 10(10), e0139206 (2015)
- Database ID:
- RPEP-02718
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02718APA
Lisowska, Barbara; Lisowski, Aleksander; Siewruk, Katarzyna. (2015). Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.. PloS one, 10(10), e0139206. https://doi.org/10.1371/journal.pone.0139206
MLA
Lisowska, Barbara, et al. "Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.." PloS one, 2015. https://doi.org/10.1371/journal.pone.0139206
RethinkPeptides
RethinkPeptides Research Database. "Substance P and Chronic Pain in Patients with Chronic Inflam..." RPEP-02718. Retrieved from https://rethinkpeptides.com/research/lisowska-2015-substance-p-and-chronic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.